Diabetes Complications
Glycemic influence extends beyond angiogenic growth factors in diabetes patients
Published in Obesity and Diabetes Week, November 3rd, 2003
"Vascular complications of chronic hyperglycemia cause most of diabetes-associated morbidity and mortality. Main targets of chronic hyperglycemia are vascular endothelial cells. Ischemia is the late consequence of vascular damage in patients with diabetes and triggers an angiogenic response," scientists in France report.
"In patients with diabetes, the angiogenic response to chronic ischemia can be excessive in some of the target organs and insufficient in others in the same individual," noted E. Larger and colleagues, College of France, INSERM.
"The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Lipid Studies
Diet affects modeling of adipose tissue triglycerides during growth - Obesity and Diabetes
Alpha-lipoic acid inhibits adipocyte differentiation - Glycemic Control
Resistance training improves glycemic control in obese type 2 diabetic men - Obesity and Diabetes
Adipose tissue as endocrine organ has impact on insulin resistance - Transplant Medicine
Diabetic liver transplant patients benefit from switching antirejection drugs - Adipose Tissue
Adipose tissue and women's health discussed - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
